Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Licogliflozin (LIK066) is an inhibitor of sodium-glucose cotransporter (SGLT1 and SGLT2).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 862.00 | |
50 mg | 6-8 weeks | $ 1,120.00 | |
100 mg | 6-8 weeks | $ 1,860.00 |
Description | Licogliflozin (LIK066) is an inhibitor of sodium-glucose cotransporter (SGLT1 and SGLT2). |
In vitro | Licogliflozin is a non-anti-fibrotic treatment compound for non-alcoholic steatohepatitis. |
Synonyms | LIK066 |
Molecular Weight | 416.46 |
Formula | C23H28O7 |
CAS No. | 1291094-73-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 2 mg/mL (4.80 mM), sonification is recommended.
DMSO: 100 mg/mL (240.12 mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Licogliflozin 1291094-73-9 GPCR/G Protein SGLT LIK 066 LIK066 inhibit Sodium-dependent glucose cotransporters LIK-066 Inhibitor inhibitor